Literature DB >> 12352115

Imaging of bilateral striopallidodentate calcinosis.

Shigeyuki Ogi1, Nobuyoshi Fukumitsu, Daisuke Tsuchida, Mayuki Uchiyama, Yutaka Mori, Kazutaka Matsui.   

Abstract

Bilateral symmetric striopallidodentate calcinosis, also known as Fahr's disease, is characterized by bilateral calcifications of the basal ganglia, thalami, dentate nuclei of the cerebellum, and the white matter of the cerebral hemisphere. Intracranial calcifications are easily visible as high-density areas on computed tomographic images. On magnetic resonance images, the calcifications exhibit different signal intensities. The differences in signal intensity are thought to be related to the stage of the disease, differences in calcium metabolism, and the volume of the calcium deposit. The moderate reduction of cerebral blood flow in bilateral thalami was also identified using brain SPECT.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12352115     DOI: 10.1097/00003072-200210000-00008

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  9 in total

1.  Neurological picture. Extensive brain calcification in idiopathic hypoparathyroidism.

Authors:  M Mejdoubi; T Zegermann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-12       Impact factor: 10.154

2.  Scintigraphic, neuroradiological and clinical comparison in two patients with primary sporadic and two with secondary Fahr's disease.

Authors:  Giovanni Caranci; Giovanni Grillea; Francesco Barbato; Alexandra Brunetti; Tiziana Tassinari; Mariarita Di Ruzza; Francesco Lena; Barbara Gandolfi; Anna Elisa Castellano; Marcello Bartolo; Claudio Colonnese; Nicola Modugno; Stefano Ruggieri; Mario Manfredi
Journal:  Neurol Sci       Date:  2010-11-06       Impact factor: 3.307

3.  Fahr's syndrome: a rare clinico-radiologic entity.

Authors:  Rajul Rastogi; A K Singh; U C Rastogi; Chander Mohan; Vaibhav Rastogi
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 4.  Gadolinium deposition within the dentate nucleus and globus pallidus after repeated administrations of gadolinium-based contrast agents-current status.

Authors:  Dragan Stojanov; Aleksandra Aracki-Trenkic; Daniela Benedeto-Stojanov
Journal:  Neuroradiology       Date:  2016-02-12       Impact factor: 2.804

5.  Evaluation of regional cerebral blood flow in fahr disease with schizophrenia-like psychosis: a case report.

Authors:  Masaru Shoyama; Masaru Shouyama; Yuji Kitabata; Tetsuji Kaku; Kazuhiro Shinosaki
Journal:  AJNR Am J Neuroradiol       Date:  2005 Nov-Dec       Impact factor: 3.825

6.  Neuropsychiatric Manifestations of Fahr's Disease, Diagnostic and Therapeutic Challenge: A Case Report and a Literature Review.

Authors:  Manuel Glauco Carbone; Filippo Della Rocca
Journal:  Clin Neuropsychiatry       Date:  2022-04

7.  Gadolinium based contrast agents in current practice: Risks of accumulation and toxicity in patients with normal renal function.

Authors:  Anju Ranga; Yatish Agarwal; Kanika J Garg
Journal:  Indian J Radiol Imaging       Date:  2017 Apr-Jun

Review 8.  Basal ganglia calcifications (Fahr's syndrome): related conditions and clinical features.

Authors:  Giulia Donzuso; Giovanni Mostile; Alessandra Nicoletti; Mario Zappia
Journal:  Neurol Sci       Date:  2019-07-02       Impact factor: 3.307

9.  Fahr's disease: a rare neurological presentation in a tropical setting.

Authors:  Akaninyene Asuquo Otu; Jude Chinedu Anikwe; Derek Cocker
Journal:  Clin Case Rep       Date:  2015-08-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.